170829 ⎘
Detection or diagnosis of diseases; Dermatological disorders Scaling palpular diseases, e.g. psoriasis, pytiriasis
PHARMACOKINETIC MODELING SYSTEMS FOR IMPROVED THERAPEUTIC DOSING
#2COMPOSITIONS, DEVICES, AND METHODS OF PSORIASIS FOOD SENSITIVITY TESTING
#3COMPOSITIONS, DEVICES, AND METHODS OF ECZEMA FOOD SENSITIVITY TESTING
#4METHODS FOR PREDICTING TREATMENT RESPONSE IN PSORIASIS
#5METHOD OF USING AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ACTIVATABLE ANTIBODY TO DETECT THE PRESENCE OR ABSENCE OF A CLEAVING AGENT AND EGFR
#6ANTI IL-36R ANTIBODIES
#7COMPOSITIONS, DEVICES, AND METHODS OF ECZEMA FOOD SENSITIVITY TESTING
#8METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS
#9BIOMARKERS AND CLASSIFIER OF PSORIASIS AND METHODS OF TREATMENT
#10NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN PREVENTING RECURRENCE OF PSORIASIS
#11BIOMARKERS ASSOCIATED WITH ANTI-IL-36R ANTIBODY TREATMENT IN GENERALIZED PUSTULAR PSORIASIS
#12Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR
#13Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#14NOVEL GENE CLASSIFIERS AND USES THEREOF IN PSORIASIS
#15Methods for diagnosing atopic dermatitis using gene classifiers
#16IL-18 binding protein (IL-18BP) in inflammatory diseases
#17NOVEL GENE CLASSIFIERS AND USES THEREOF IN AUTOIMMUNE DISEASES
#18Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies
#19ANTI IL-36R ANTIBODIES
#20Differential diagnosis of eczema and psoriasis
#21Method for Evaluating Health of Skin
#22Lytic peptide biosensor and methods of making and using the same
#23LYTIC PEPTIDE BIOSENSOR AND METHODS OF MAKING AND USING THE SAME
#24Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#25Complex-specific standardization of immunological methods for the quantification of S100A12
#26Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#27COMPOSITIONS, DEVICES, AND METHODS OF PSORIASIS FOOD SENSITIVITY TESTING
#28Identification of Biomarkers in Serum Samples Collected from Clinical Trials by Multiplex Technology
#29ANTI IL-36R ANTIBODIES
#30Methods, agents and compositions for treatment of inflammatory conditions
#31Antibodies against human sodium channel nav 1.9
#32Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor
#33Herbal Combinations For Treating Psoriasis
#34DIFFERENTIAL DIAGNOSIS OF ECZEMA AND PSORIASIS
#35Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#36Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#37IL-18 binding protein (IL-18BP) in inflammatory diseases
#38Activated HER3 as a marker for predicting therapeutic efficacy
#39Methods for detecting antibodies
#40TREATING DISEASES BY MODULATING A SPECIFIC ISOFORM OF MKL1
#41Anti IL-36R antibodies
#42Anti-αβantibodies
#43Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
#44Granzyme A and granzyme B diagnostics
#45Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease
#46Anti IL-36R antibodies
#47CANCER THERAPY
#48ANTI-ALPHA V BETA 6 ANTIBODIES
#49Methods of treating lupus
#50Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
#51GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#52CD109 POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF SKIN CELLS
#53Tape stripping methods for analysis of skin desease and pathological skin state
#54Naphthalene-based inhibitors of anti-apoptotic proteins
#55GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#56Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#57Novel composition and methods for the treatment of psoriasis
#58BIOMARKERS FOR THE TREATMENT OF PSORIASIS
#59Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
#60Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
#61INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS
#62METHOD FOR DETERMINING THE STATE OF A SKIN DISORDER USING NEAR INFRARED (NIR) SPECTROSCOPY
#63Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
#64SELECTIVE DIFFERENTIATION, IDENTIFICATION, AMD MODULATION OF HUMAN TH17 CELLS
#65NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PSORIASIS
#66Use application of sugar chain-recognizing receptor
#67Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
#68PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES
#69Granzyme A and granzyme B diagnostics
#70Naphthalene-based inhibitors of anti-apoptotic proteins
#71METHOD FOR DETECTION OF A DISEASE-SPECIFIC COMBINATORIAL MOLECULAR PATTERN MOTIF IN A TISSUE SAMPLE OF A PATIENT'S SKIN
#72NON-INVASIVE METHOD FOR COLLECTING BIOLOGICAL DATA FOR ESTABLISHING A DIAGNOSIS OF A CUTANEOUS PATHOLOGY
#73Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
#74METHOD FOR IDENTIFICATION OF SOMATIC STEM CELLS
#75ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY
#76IMPROVEMENTS IN RELATION TO CANCER THERAPY
#77Filaggrin
#78Novel compositions and method for the treatment of psoriasis
#79Method for evaluating skin condition using squamous cell carcinoma antigen as marker
#80Anti-αβantibodies
#81NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#82Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#83Novel composition and methods for the treatment of psoriasis
#84Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
#85Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
#86DIAGNOSIS AND TREATMENT OF DISEASE
#87Methods and reagents for identifying/isolating T regulatory (Treg) cells and for treating individuals
#88Use of AIM3 acting as a tumor suppressor
#89BIOMARKER IN INFLAMMATORY DISEASES
#90Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#91Treatment and Diagnostics of Inflammatory Diseases
#92Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
#93Tape stripping methods for analysis of skin disease and pathological skin state
#94Novel ubp8rp polypeptides and their use in the treatment of psoriasis
#95Characterization of microbial deposition and immune response at the basement membrane and methods relating thereto
#96Nouvelles compositions et methods de traitement du psoriasis
#97Method for identification of somatic stem cells
#98Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
#99Immunologic activity measures for t helper on-associated conditions
#100Novel composition and methods for the treatment of psoriasis
#101Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
#102Novel use of aim 3 acting as a tumor suppressor
#103Anti-αβantibodies
#104Tape stripping methods for analysis of skin disease and pathological skin state